Search

Displaying results 7911 - 7920 of 10000 in total
  1. Drug

    Biphenyl dimethyl dicarboxylate

    go.drugbank.com/drugs/DB12475
    Investigational

    Nissel has been investigated for the treatment of Chronic Liver Disease.

  2. Drug

    Forigerimod

    go.drugbank.com/drugs/DB12490
    Investigational

    Forigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic.

  3. Drug

    PF-00446687

    go.drugbank.com/drugs/DB12517
    Investigational

    PF-00446687 has been investigated for the treatment of Erectile Dysfunction.

    Categories: Receptor, Melanocortin, Type 4, agonists
  4. Drug

    Combretastatin

    go.drugbank.com/drugs/DB12596
    Investigational

    Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.

  5. Drug

    Intetumumab

    go.drugbank.com/drugs/DB12701
    Investigational

    Intetumumab has been used in trials studying the treatment of Melanoma.

  6. Drug

    beta-Apopicropodophyllin

    go.drugbank.com/drugs/DB15590
    Experimental

    beta-Apopicropodophyllin is a component of the freshwater plant _Micranthemum umbrosum_.

  7. Drug

    N-Ethylretinamide

    go.drugbank.com/drugs/DB03917
    Experimental

    N-Ethylretinamide is the ethylamide of all-trans B-retinoic acid.

  8. Drug

    Vevorisertib

    go.drugbank.com/drugs/DB21481
    Investigational

    The usage of the INN stem '-sertib' in the name indicates that Vevorisertib is a serine/threonine kinase inhibitor.

  9. Drug

    Inactivated SARS-CoV-2 Vaccine (Chinese Academy of Medical Sciences)

    go.drugbank.com/drugs/DB15863
    Experimental

    The SARS-CoV-2 Inactivated Vaccine is a purified vaccine that contains multiple antigens from the virus and is inactivated in Vero Cells[A219758]. … This vaccine specifically was developed in collaboration with the Chinese Academy of Medical Sciences, West China Second University Hospital, and Yunan Center for Disease Control and Prevention.

  10. Drug

    Tizaterkib

    go.drugbank.com/drugs/DB21296
    Investigational

    The usage of the INN stem '-terkib' in the name indicates that Tizaterkib is a extracellular signal-regulated kinase (ERK) inhibitor.